3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
pembrolizumab
69
Nivolumab
39
Cyclophosphamide
35
Carboplatin
27
Dexamethasone
23
Specimen Handling
22
Paclitaxel
22
Lenalidomide
22
durvalumab
20
Radiotherapy
19
Gemcitabine
19
venetoclax
18
Magnetic Resonance Spectroscopy
18
Doxorubicin
17
Rituximab
16
Ipilimumab
16
fludarabine
15
Bevacizumab
15
Biopsy
14
atezolizumab
13
Etoposide
13
Vincristine
12
Cisplatin
12
Azacitidine
12
belantamab mafodotin
11
Pemetrexed
11
Docetaxel
11
Calcium Dobesilate
11
olaparib
10
Oxaliplatin
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Active not recruiting
×
Maintenance
×
Clear all
NCT04542824
2026-05-05
EPCOREâ„¢ NHL-3
Genmab
Phase 1/2
Active not recruiting
78 enrolled